Product Information
BUPROPION HCL 75 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0955 per EA under NDC 59651087401. Its NADAC has been published 70 times since Feb 26, 2025.
Strength
75 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651087401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075491On Market Since
4/25/2024
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL 75 MG TABLET has been published 70 times since Feb 26, 2025, and over the history we have for it it has declined 2.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0955 per EA |
|---|---|
| All-time high | $0.1021 (Jul 16, 2025) |
| All-time low | $0.0951 (Feb 18, 2026) |
| 52-week high | $0.1021 |
| 52-week low | $0.0951 |
| Median price | $0.0987 |
| Average price | $0.0987 |
| Largest weekly change | +4.2% (Mar 19, 2025) |
| Weeks tracked | 70 |
| Tracking since | Feb 26, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the BUPROPION HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BUPROPION HCL 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL 75 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0955 per EA (NDC 59651087401), effective Jun 24, 2026.
How has the price of BUPROPION HCL 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL 75 MG TABLET has declined 2.2%. It has been tracked across 70 weekly CMS publications since Feb 26, 2025.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL 75 MG TABLET?
Since Feb 26, 2025, the NADAC for BUPROPION HCL 75 MG TABLET has ranged from a low of $0.0951 (Feb 18, 2026) to a high of $0.1021 (Jul 16, 2025), with a median of $0.0987 per EA.
Are there cheaper alternatives to BUPROPION HCL 75 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUPROPION HCL 75 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures BUPROPION HCL 75 MG TABLET?
BUPROPION HCL 75 MG TABLET (NDC 59651087401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification